Recombinant RSV antigens

Details for Australian Patent Application No. 2008340949 (hide)

Owner ID Biomedical Corporation of Quebec GlaxoSmithKline Biologicals S.A.

Inventors Rheault, Patrick; Baudoux, Jean-Pierre; Ruelle, Jean-Louis; Blais, Normand

Agent Davies Collison Cave

Pub. Number AU-A-2008340949

PCT Pub. Number WO2009/079796

Priority 61/056,206 27.05.08 US; 61/016,524 24.12.07 US

Filing date 23 December 2008

Wipo publication date 2 July 2009

International Classifications

C07K 19/00 (2006.01) Hybrid peptides

A61K 9/107 (2006.01) Medicinal preparations characterised by special physical form - Emulsions

A61K 9/127 (2006.01) Medicinal preparations characterised by special physical form - Liposomes

A61K 39/00 (2006.01) Medicinal preparations containing antigens or antibodies

A61K 39/155 (2006.01) Medicinal preparations containing antigens or antibodies - Paramyxoviridae, e.g. parainfluenza virus

A61K 39/295 (2006.01) Medicinal preparations containing antigens or antibodies - Polyvalent viral antigens

A61P 31/14 (2006.01) Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics

A61P 37/04 (2006.01) Drugs for immunological or allergic disorders

C07K 14/135 (2006.01) Peptides having more than 20 amino acids

C12N 15/45 (2006.01) Mutation or genetic engineering

C12N 15/62 (2006.01) Mutation or genetic engineering - DNA sequences coding for fusion proteins

Event Publications

22 July 2010 PCT application entered the National Phase

  PCT publication WO2009/079796 Priority application(s): WO2009/079796

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2008340991-Indazolyl, benzimidazolyl, benzotriazolyl substituted indolinone derivatives as kinase inhibitors useful in the treatment of cancer

2008340943-Polypeptide-nucleic acid conjugates and uses thereof